JPRN-UMIN000020742已完成未知
The efficacy of the administration of SGLT-2 inhibitor and/or DPP-4 inhibitor in type 2 diabetic patient with basal-bolus insulin therapy. - The effect of SGLT-2 administration on nocturnal hypoglycemia.
Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School0 个研究点目标入组 60 人开始时间: 2016年1月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Type 1 diabetes renal dysfunction hepatic dysfunction
研究者
相似试验
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte
已完成
不适用
The efficacy and safety of SGLT2 inhibitor for non alcholic fatty liver disease in Japanese patients with type 2 diabetesJPRN-UMIN000016306Tokyo Medical and Dental University50
已完成
不适用
Efficacy and Safety of SGLT-2 inhibitor to break loose from glucose toxicity and to withdraw insulin therapy in type 2 diabetic inpatientsJPRN-UMIN000013539Shiga University of Medical Science Department of Internal Medicine Division of Diabetology, Nephrology, Neurology20
已完成
不适用
ong-term efficacy and safety of the SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus.JPRN-UMIN000037872akakinen Clinic630
尚未招募
Unknown
Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysisChronic kidney disease under peritoneal dialysisJPRN-UMIN000049848International University of Health and Welfare10